Brand names: Memantine Hydrochloride
12.1 Mechanism of Action Persistent activation of central nervous system N-methyl-D-aspartate (NMDA) receptors by the excitatory amino acid glutamate has been hypothesized to contribute to the symptomatology of Alzheimer's disease. Memantine is postulated to exert its therapeutic effect through its action as a low to moderate affinity uncompetitive (open-channel) NMDA receptor antagonist which binds preferentially to the NMDA receptor-operated cation channels. There is no evidence that memantine prevents or slows neurodegeneration in patients with Alzheimer's disease.
10 documented side effects by frequency
No community discussions found for MEMANTINE HYDROCHLORIDE yet.
Every figure on this page links back to its primary source. See data sources for full provenance.
8 available comparisons
Dosage Forms
Tablet
Route
Oral